Please use this identifier to cite or link to this item: https://ninho.inca.gov.br/jspui/handle/123456789/10608
Full metadata record
DC FieldValueLanguage
dc.contributor.authorInstituto Nacional de Câncer José Alencar Gomes da Silva-
dc.contributor.authorInstituto Nacional de Câncer (Brasil)-
dc.contributor.authorINCA-
dc.date.accessioned2022-09-02T17:51:16Z-
dc.date.available2022-09-02T17:51:16Z-
dc.date.issued2022-07-
dc.identifier.urihttp://sr-vmlxaph03:8080/jspui/handle/123456789/10608-
dc.publisherINCApt_BR
dc.subjectUso Indevido de Medicamentos/prevenção & controlept_BR
dc.subjectDrug Misuse/prevention & controlpt_BR
dc.subjectAbuso de Medicamentos/prevención & controlpt_BR
dc.subjectTécnicas de Pesquisapt_BR
dc.subjectInvestigative Techniquespt_BR
dc.subjectTécnicas de Investigaciónpt_BR
dc.subjectProtocolos Clínicos/normaspt_BR
dc.subjectClinical Protocols/standardspt_BR
dc.subjectExperimentação Humanapt_BR
dc.subjectHuman Experimentationpt_BR
dc.subjectExperimentación Humanapt_BR
dc.titlePesquisa Clínica alerta sobre notificação dos efeitos adversos e uso incorreto de medicamentospt_BR
dc.title.alternativeInforme INCA 421pt_BR
dc.TypeArticlept_BR
Appears in Collections:Informe INCA 421

Files in This Item:
File Description SizeFormat 
Informe-INCA-2022-421-10-Pesquisa-Clínica-alerta.pdf362.05 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.